It has been shown that obesity-associated systemic factors reduce ESR2 expression, which may function as a compensatory mechanism to limit lipogenesis and lipolysis in adipose tissue [24]. The gene discussed is ESR2; the disease is obesity due to melanocortin 4 receptor deficiency.